Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

RTI, Aesculap in spinal allograft agreement

This article was originally published in Clinica

Executive Summary

RTI Biologics is set to provide its spinal allograft implants to German surgical instruments specialist Aesculap Implant Systems. As part of a new deal between the two firms, RTI (Alachua, Florida) will manufacture cervical and lumbar spinal grafts from designs developed by Aesculap. This deal sees Tuttlingen-based Aesculap boost its range of spine-related products, which include anterior thoracolumbar, cervical spine, interbody fusion and posterior spine implants, as well as osteobiological matrix putty. Financial terms of the agreement were not revealed.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT041713

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel